Sponsored Content
- Sponsored Content
- Analytical
Innovative Approaches to Enhance Cell Culture Density for High-Quality Production
BPI Contributor
September 19, 2024
15 Min View
Date: Sep 19, 2024
Duration: 15 Min
Already have an account?
Sponsored by Samsung Biologics
This webcast features: Hakyung Kim, Senior Scientist, Upstream Process Development & Dongyoung Park, Senior Scientist, Upstream Process Development, Samsung Biologics.
Recent innovations in intensified fed-batch (IFB) processing have dramatically improved cell culture yields and scalability, offering a powerful solution for optimizing biopharmaceutical production. By incorporating the IFB approach, Samsung Biologics has developed a platform that optimizes crucial process parameters to maximize the productivity of cultured cell lines.
Join Samsung Biologics for this webinar as they explore the latest advancements in IFB processing and discuss how our novel platform, S-Tensify™, ensures consistent quality and productivity in an increasingly complex production landscape.
Key Takeaways:
Learn how Samsung Biologics integrated intensified fed-batch (IFB) processing to achieve higher densities of viable cells during the N-1 step.
Discover how Samsung Biologics’ IFB platform, S-Tensify™, optimizes cell culture processes, enhancing yield and material quality.
Explore case studies that demonstrate a 30-fold increase in inoculation cell density using the S-Tensify™ platform.
Register or Login and hit Watch on Demand to view the recorded webcast now.
About the Author
You May Also Like
Sponsored Content
Jun 5 - Jun 6, 2024
Jun 5 - Jun 6, 2024
Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization
Learn More
